THE EFFECTS OF DANSHEN (SALVIA-MILTIORRHIZA) ON WARFARIN PHARMACODYNAMICS AND PHARMACOKINETICS OF WARFARIN ENANTIOMERS IN RATS

被引:87
|
作者
CHAN, K
LO, ACT
YEUNG, JHK
WOO, KS
机构
[1] CHINESE UNIV HONG KONG,DEPT PHARMACOL,HONG KONG,HONG KONG
[2] CHINESE UNIV HONG KONG,DEPT MED,HONG KONG,HONG KONG
关键词
D O I
10.1111/j.2042-7158.1995.tb05819.x
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The effects of Danshen (Salvia miltiorrhiza), a popular traditional Chinese medicinal herb on the pharmacokinetics and pharmacodynamics of R- and S-warfarin stereoisomers were studied in rats. After a single oral dose of racemic warfarin (2 mg kg(-1)), treatment with oral Danshen extract (5 g kg(-1) twice daily) for 3 days significantly altered the overall pharmacokinetics of both R- and S-warfarin and increased the plasma concentrations of both enantiomers over a period of 24 h and the prothrombin time over 2 days. At steady-slate levels of racemic warfarin (0.2 mg kg day(-1) for 5 days) the 3-day treatment of Danshen extract (5 g kg(-1), twice daily) not only prolonged the prothrombin time but also increased the steady-state plasma concentrations of R- and S-warfarin. The results indicate that Danshen extracts can increase the absorption rate constant, area under plasma concentration-time curves, maximum concentrations and elimination half-lives, but decreases the clearances and apparent volume of distribution of both R- and S-warfarin. The pharmacokinetic and pharmacodynamic interactions of warfarin during co-treatment with Danshen extract observed in this study indicate an explanation for the clinically observed incidents of exaggerated warfarin adverse effects when traditional Chinese medicinal herbs or herbal products such as Danshen and Danggui (observed in a previous study) were co-administered.
引用
收藏
页码:402 / 406
页数:5
相关论文
共 50 条
  • [31] Effect of aprepitant on the pharmacokinetics and pharmacodynamics of warfarin
    Depré, M
    van Hecken, A
    Oeyen, M
    de Lepeleire, I
    Laethem, T
    Rothenberg, P
    Petty, K
    Majumdar, A
    Crumley, T
    Panebianco, D
    Bergman, A
    de Hoon, JN
    [J]. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2004, 58 (01) : 104 - 105
  • [32] Effect of rosuvastatin on warfarin pharmacodynamics and pharmacokinetics
    Simonson, SG
    Martin, PD
    Mitchell, PD
    Lasseter, K
    Gibson, G
    Schneck, DW
    [J]. JOURNAL OF CLINICAL PHARMACOLOGY, 2005, 45 (08): : 927 - 934
  • [33] Effect of aprepitant on the pharmacokinetics and pharmacodynamics of warfarin
    Depré, M
    Van Hecken, A
    Oeyen, M
    De Lepeleire, I
    Laethem, T
    Rothenberg, P
    Petty, KJ
    Majumdar, A
    Crumley, T
    Panebianco, D
    Bergman, A
    de Hoon, JN
    [J]. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2005, 61 (5-6) : 341 - 346
  • [34] The effect of etoricoxib on the pharmacodynamics and pharmacokinetics of warfarin
    Schwartz, Jules I.
    Agrawal, Nancy G. B.
    Hartford, Alan H.
    Cote, Josee
    Hunt, Thomas L.
    Verbesselt, Rene
    Eckols, Dane R.
    Gottesdiener, Keith M.
    [J]. JOURNAL OF CLINICAL PHARMACOLOGY, 2007, 47 (05): : 620 - 627
  • [35] The effect of rofecoxib on the pharmacodynamics and pharmacokinetics of warfarin
    Schwartz, JI
    Bugianesi, KJ
    Ebel, DL
    De Smet, M
    Haesen, R
    Larson, PJ
    Ko, A
    Verbesselt, R
    Hunt, TL
    Lins, R
    Lens, S
    Porras, AG
    Dieck, J
    Keymeulen, B
    Gertz, BJ
    [J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 2000, 68 (06) : 626 - 636
  • [36] Effect of ciprofloxacin on the pharmacokinetics and pharmacodynamics of warfarin
    Israel, DS
    Stotka, J
    Rock, W
    Sintek, CD
    Kamada, AK
    Klein, C
    Swaim, WR
    Pluhar, RE
    Toscano, JP
    Lettieri, JT
    Heller, AH
    Polk, RE
    [J]. CLINICAL INFECTIOUS DISEASES, 1996, 22 (02) : 251 - 256
  • [37] Effect of Cilostazol on the Pharmacokinetics and Pharmacodynamics of Warfarin
    Suresh Mallikaarjun
    Steven L. Bramer
    [J]. Clinical Pharmacokinetics, 1999, 37 : 79 - 86
  • [38] Effect of cilostazol on the pharmacokinetics and pharmacodynamics of warfarin
    Mallikaarjun, S
    Bramer, SL
    [J]. CLINICAL PHARMACOKINETICS, 1999, 37 (Suppl 2) : 79 - 86
  • [39] Effect of nilotinib on the pharmacokinetics and pharmacodynamics of warfarin
    Yin, O.
    Gallagher, N. J.
    Fischer, D.
    Zhao, L.
    Zhou, W.
    Golor, G.
    Schran, H.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
  • [40] Effects of lasofoxifene on the pharmacokinetics and pharmacodynamics of single-dose warfarin
    Ouellet, D
    Bramson, C
    Carvajal-Gonzalez, S
    Roman, D
    Randinitis, E
    Remmers, A
    Gardner, MJ
    [J]. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2006, 61 (06) : 741 - 745